AR063319A1 - Proceso mejorado para preparar la forma polimorfica i de clorhidrato de donepezilo (2,3-dihidro-5,6-dimetoxi-2-[[1-(fenilmetil)-4-piperidin]metil-1h-inden-1-ona) - Google Patents

Proceso mejorado para preparar la forma polimorfica i de clorhidrato de donepezilo (2,3-dihidro-5,6-dimetoxi-2-[[1-(fenilmetil)-4-piperidin]metil-1h-inden-1-ona)

Info

Publication number
AR063319A1
AR063319A1 ARP070104582A ARP070104582A AR063319A1 AR 063319 A1 AR063319 A1 AR 063319A1 AR P070104582 A ARP070104582 A AR P070104582A AR P070104582 A ARP070104582 A AR P070104582A AR 063319 A1 AR063319 A1 AR 063319A1
Authority
AR
Argentina
Prior art keywords
polymorphic form
donepezyl
dimetoxi
chlorhydrate
inden
Prior art date
Application number
ARP070104582A
Other languages
English (en)
Inventor
Madrid Nuria Soldevilla
Original Assignee
Medichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem Sa filed Critical Medichem Sa
Publication of AR063319A1 publication Critical patent/AR063319A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Un proceso para preparar una forma polimorfica 1 de clorhidrato de donepezilo que es muy estable respecto de la conversion en otras formas polimorficas, caracterizado porque comprende: i. disolver clorhidrato de donepezilo en metanol y una pequena cantidad de agua con calentamiento; ii. enfriar la solucion; iii. poner en contacto la solucion del paso (ji) con al menos un solvente no polar, o mezclas de dichos solventes; iv. aislar la forma polimorfica 1 humeda de clorhidrato de donepezilo obtenida en el paso (iii); y v. eliminar al menos una porcion del metanol residual de la forma poIimorfica 1 humeda de clorhidrato de donepezilo obtenida en el paso (iv).
ARP070104582A 2006-10-16 2007-10-16 Proceso mejorado para preparar la forma polimorfica i de clorhidrato de donepezilo (2,3-dihidro-5,6-dimetoxi-2-[[1-(fenilmetil)-4-piperidin]metil-1h-inden-1-ona) AR063319A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85175706P 2006-10-16 2006-10-16
US92919507P 2007-06-18 2007-06-18

Publications (1)

Publication Number Publication Date
AR063319A1 true AR063319A1 (es) 2009-01-21

Family

ID=39712458

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104582A AR063319A1 (es) 2006-10-16 2007-10-16 Proceso mejorado para preparar la forma polimorfica i de clorhidrato de donepezilo (2,3-dihidro-5,6-dimetoxi-2-[[1-(fenilmetil)-4-piperidin]metil-1h-inden-1-ona)

Country Status (2)

Country Link
AR (1) AR063319A1 (es)
WO (1) WO2008117123A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060752B (zh) * 2011-01-24 2013-03-13 上海右手医药科技开发有限公司 高纯度盐酸多奈哌齐无水i晶型的生产方法及其产品
CN103694164B (zh) * 2014-01-23 2015-08-12 天津大学 一种盐酸多奈哌齐新晶型及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046526A1 (en) * 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
EP1858847A1 (en) * 2005-02-28 2007-11-28 Ranbaxy Laboratories Limited Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
US20090253746A1 (en) * 2005-11-14 2009-10-08 Nuria Soldevilla Madrid Synthesis and Preparations of Intermediates and New Polymorphs Thereof Useful For The Preparation Of Donepezil Hydrochlcoride
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.

Also Published As

Publication number Publication date
WO2008117123A2 (en) 2008-10-02
WO2008117123A3 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
AR075672A1 (es) Composicion detergente para lavado de ropa
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
AR060894A1 (es) Aparato basado en membrana y metodo asociado
AR060893A1 (es) Articulo basado en membrana y metodo asociado
NO20050801L (no) Prodrug av protonpumpe inhibitorer
BRPI0812641A2 (pt) "processo de destilação extrativa (ed) aperfeiçoada para desidratar um material de partida aquoso que contém etanol e água, processo aperfeiçoado para desidratar um material de partida aquoso que contém etanol e água"
NO20071095L (no) Hittil ukjente tiofenderivater
CO6321254A2 (es) Pirimidin -5-carboxamidas sustituidas 281
CL2011001992A1 (es) Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto.
AR065797A1 (es) Usos y derivados de 1-(2- (2,4- dimetilfenilsulfanil) fenil) piperazina
DOP2010000375A (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato
DK1811957T3 (da) Fast farmaceutisk sammensætning omfattende donepezilhydrochlorid
NO20051860L (no) Rengjoringsmiddel som inneholder en hydrofiliserende polymer
DOP2006000190A (es) Composición limpiadora ácida que contiene un polímero de hidrofilización
AR051020A1 (es) Mejoras de composiciones organicas o relacionadas con las mismas
RS52676B (en) 4- [2- (4-METHYLPHENYLSULPHANYL) PHENYL] PIPERIDINE WITH COMBINED SEROTONINE AND NOREPINEPHRINE REHIBITION FOR THE TREATMENT OF ADHD, MELANCHOLIA, TREATMENT-RESISTANT DISPOSAL, OR SIMPRESSION
AR073204A1 (es) Tratamientos de bananas.
AR071605A1 (es) Concentrado de proteina vegetal
AR045094A1 (es) Formulaciones liofilizadas de cci-779
AR063319A1 (es) Proceso mejorado para preparar la forma polimorfica i de clorhidrato de donepezilo (2,3-dihidro-5,6-dimetoxi-2-[[1-(fenilmetil)-4-piperidin]metil-1h-inden-1-ona)
NO20052557L (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
ATE537245T1 (de) Verbesserungen bei behandlungsmitteln für harte oberflächen
ES2557880T3 (es) Método de tratamiento de café
DE60211300D1 (de) Verbesserungen bei flüssigen waschmitteln
FR2885910A1 (fr) Composition aqueuse de nettoyage pour le traitement du cuivre de semi-conducteurs

Legal Events

Date Code Title Description
FB Suspension of granting procedure